| OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis |
177 |
| Osteoarthritis year in review 2017: clinical |
44 |
| Osteoarthritis and stem cell therapy in humans: a systematic review |
28 |
| A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee |
27 |
| Parkin clearance of dysfunctional mitochondria regulates ROS levels and increases survival of human chondrocytes |
26 |
| Models of osteoarthritis: the good, the bad and the promising |
24 |
| Identification of transcription factors responsible for dysregulated networks in human osteoarthritis cartilage by global gene expression analysis |
24 |
| Osteoarthritis year in review 2018: clinical |
23 |
| Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the Osteoarthritis Initiative |
21 |
| Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review |
21 |
| Knee menisci segmentation using convolutional neural networks: data from the Osteoarthritis Initiative |
20 |
| Model-based pain and function outcome trajectory types for patients undergoing knee arthroplasty: a secondary analysis from a randomized clinical trial |
20 |
| NLRP3 as a potentially novel biomarker for the management of osteoarthritis |
19 |
| The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: a network meta-analysis of randomised controlled trials |
18 |
| The importance of synovial inflammation in osteoarthritis: current evidence from imaging assessments and clinical trials |
18 |
| Activation of AMPK-SIRT3 signaling is chondroprotective by preserving mitochondrial DNA integrity and function |
17 |
| Bone morphogenetic proteins for articular cartilage regeneration |
17 |
| Systematic review and meta-analysis of the reliability and discriminative validity of cartilage compositional MRI in knee osteoarthritis |
17 |
| Total knee replacement and non-surgical treatment of knee osteoarthritis: 2-year outcome from two parallel randomized controlled trials |
17 |
| Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment |
16 |
| Osteoarthritis induced by destabilization of the medial meniscus is reduced in germ-free mice |
15 |
| Osteoarthritis year in review 2017: biology |
15 |
| Dual-energy computed tomography in calcium pyrophosphate deposition: initial clinical experience |
15 |
| The effects of metabolic syndrome, obesity, and the gut microbiome on load-induced osteoarthritis |
14 |
| Osteoarthritis year in review 2018: biomarkers (biochemical markers) |
14 |
| Osteoarthritis biomarkers: year in review |
14 |
| Mechanisms of endogenous repair failure during intervertebral disc degeneration |
14 |
| Cartilage oligomeric matrix protein, C-terminal cross-linking telopeptide of type II collagen, and matrix metalloproteinase-3 as biomarkers for knee and hip osteoarthritis (OA) diagnosis: a systematic review and meta-analysis |
14 |
| Nutrient supply and nucleus pulposus cell function: effects of the transport properties of the cartilage endplate and potential implications for intradiscal biologic therapy |
14 |
| The burden for knee osteoarthritis among Chinese elderly: estimates from a nationally representative study |
13 |
| Pharmacological inhibition of mTORC1 but not mTORC2 protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism through Akt and autophagy induction |
13 |
| TGF-beta signaling in intervertebral disc health and disease |
13 |
| A machine learning approach to knee osteoarthritis phenotyping: data from the FNIH Biomarkers Consortium |
13 |
| Wnt5a suppresses inflammation-driven intervertebral disc degeneration via a TNF-alpha/NF-kappa B-Wnt5a negative-feedback loop |
13 |
| TFEB protects nucleus pulposus cells against apoptosis and senescence via restoring autophagic flux |
12 |
| Osteoarthritis year in review 2018: genetics and epigenetics |
12 |
| A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial |
12 |
| Relationship between knee joint contact forces and external knee joint moments in patients with medial knee osteoarthritis: effects of gait modifications |
12 |
| Type 2 diabetes patients have accelerated cartilage matrix degeneration compared to diabetes free controls: data from the Osteoarthritis Initiative |
12 |
| The risk of symptomatic knee osteoarthritis after arthroscopic meniscus repair vs partial meniscectomy vs the general population |
12 |
| Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials |
12 |
| Lack of beneficial effects of low-dose radiation therapy on hand osteoarthritis symptoms and inflammation: a randomised, blinded, sham-controlled trial |
12 |
| Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA) |
11 |
| Diagnosing osteoarthritis from T-2 maps using deep learning: an analysis of the entire Osteoarthritis Initiative baseline cohort |
11 |
| Physical therapy vs internet-based exercise training for patients with knee osteoarthritis: results of a randomized controlled trial |
11 |
| Mechanical loading inhibits cartilage inflammatory signalling via an HDAC6 and IFT-dependent mechanism regulating primary cilia elongation |
10 |
| CD146/MCAM distinguishes stem cell subpopulations with distinct migration and regenerative potential in degenerative intervertebral discs |
10 |
| Intra-articular injection of mesenchymal stem cells in treating knee osteoarthritis: a systematic review of animal studies |
10 |
| Incremental clinical effectiveness and cost effectiveness of providing supervised physiotherapy in addition to usual medical care in patients with osteoarthritis of the hip or knee: 2-year results of the MOA randomised controlled trial |
10 |
| Increased susceptibility to develop spontaneous and post-traumatic osteoarthritis in Dot1l-deficient mice |
10 |
